Xponance’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
18,786
+266
+1% +$3.18K ﹤0.01% 1502
2026
Q1
$111K Buy
18,520
+5,233
+39% +$39.4K ﹤0.01% 1564
2025
Q4
$95.3K Sell
13,287
-2,596
-16% -$20.5K ﹤0.01% 1471
2025
Q3
$170K Sell
15,883
-521
-3% -$5.11K ﹤0.01% 1382
2025
Q2
$159K Buy
16,404
+2,576
+19% +$26.6K ﹤0.01% 1357
2025
Q1
$206K Buy
13,828
+1,823
+15% +$28K ﹤0.01% 1259
2024
Q4
$179K Buy
+12,005
New +$196K ﹤0.01% 1311
2024
Q2
Sell
-13,683
Closed -$257K 1354
2024
Q1
$257K Buy
13,683
+2,847
+26% +$48.9K ﹤0.01% 1105
2023
Q4
$156K Sell
10,836
-31,699
-75% -$431K ﹤0.01% 1182
2023
Q3
$738K Buy
42,535
+1,798
+4% +$37.5K 0.01% 750
2023
Q2
$848K Buy
40,737
+1,669
+4% +$36.3K 0.01% 704
2023
Q1
$919K Buy
39,068
+2,383
+6% +$64K 0.01% 660
2022
Q4
$1.02M Buy
36,685
+6,342
+21% +$162K 0.02% 632
2022
Q3
$710K Buy
30,343
+5,438
+22% +$164K 0.01% 696
2022
Q2
$841K Buy
24,905
+8,990
+56% +$315K 0.02% 628
2022
Q1
$556K Buy
15,915
+499
+3% +$17.1K 0.01% 859
2021
Q4
$469K Buy
15,416
+2,729
+22% +$88.9K 0.01% 925
2021
Q3
$416K Sell
12,687
-1,613
-11% -$51.6K 0.01% 965
2021
Q2
$433K Buy
+14,300
New +$471K 0.01% 977

Other funds holding OGN

Xponance's OGN Position: Q2 2026 in Review

Xponance increased its Organon & Co (OGN) stake by 1.4% in Q2 2026, buying an estimated $3.18K and bringing the position to 18,786 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1502.

Xponance first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.02M in Q4 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Xponance held 18,786 shares of Organon & Co worth $254K as of Q2 2026.
  • Xponance bought 266 Organon & Co shares in Q2 2026, an estimated $3.18K.
  • Organon & Co made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1502 holding.
  • Xponance first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
  • Xponance's Organon & Co position peaked at $1.02M in Q4 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.